Group 1 - The core announcement is that BeiGene (06160.HK) issued 741,300 ordinary shares on March 11, 2026, under the revised and restated 2018 employee stock option plan [1]

Core Viewpoint - The company anticipates a decline in sales for its main brand during the peak season due to unexpected cold weather and intensified competition, leading to a downward revision of profit forecasts for FY26-28. However, the company maintains solid operational quality and a positive outlook for sustainable high-quality performance growth through product innovation and brand leadership strategies [1]. Group 1: Sales and Revenue Forecast - The main brand is expected to see a single-digit revenue growth in FY26, with a slowdown in growth rate in the second half compared to the first half, primarily due to fluctuating and warmer weather affecting down jacket demand [2]. - The company expects its direct sales to outperform distribution channels, with overall offline sales remaining stable and online sales driving revenue growth [2]. - OEM business revenue is projected to decline in FY26 due to tariff disruptions and weak terminal demand, but is expected to return to approximately 10% growth in FY27 due to new customer onboarding and capacity expansion [2]. Group 2: Profitability and Margin Outlook - The company anticipates that the gross margin for the main brand and OEM business will remain stable, with overall group gross margin benefiting from structural changes in OEM and down jackets, expected to rise moderately in FY26 [3]. - The company is maintaining prudent discount levels and effective inventory management, leading to healthy inventory levels and improved average selling prices (ASP) for new products, although warmer weather may temporarily increase the proportion of lower-margin lightweight products [3]. Group 3: Earnings Forecast and Valuation - The company has revised down its net profit forecasts for FY26-28 by 4.2%, 6.9%, and 10.1% to 3.74 billion, 4.04 billion, and 4.33 billion yuan respectively, primarily due to anticipated slower revenue growth for the main brand in the second half of FY26 and ongoing declines in OEM revenue [3]. - The target price has been adjusted down by 7% to 5.41 HKD, with a revised price-to-earnings (PE) ratio of 14X for FY26, reflecting a slight slowdown in short-term growth [3].

Group 1 - The core point of the article is that China National Pharmaceutical Group (国药控股) will hold a board meeting on March 20, 2026, to consider and approve the annual performance for the twelve months ending December 31, 2025, and to declare dividends if applicable [1] Group 2 - The meeting is scheduled for a Friday, indicating a strategic timing for financial disclosures [1] - The focus will be on both the company and its subsidiaries, highlighting the importance of consolidated performance [1] - The announcement suggests a forward-looking approach to financial management and shareholder returns [1]

Core Viewpoint - The company, HeartLink Medical-B (02160.HK), announced a change in its presentation currency from Renminbi to US Dollars, effective from the fiscal year ending December 31, 2025, to align with its global strategy and improve financial clarity for shareholders and potential investors [1]. Financial Reporting Changes - The first consolidated financial statements presented in US Dollars will be for the fiscal year ending December 31, 2025 [1]. - The change in presentation currency will be applied retrospectively, with comparative figures for 2024 being restated in US Dollars [1]. - The company anticipates that this change and the restatement of comparative figures will not have a significant impact on its consolidated financial statements [1].

此外，英伟达与NEBIUS达成战略合作，共同开发并部署面向AI市场的新一代超大规模云服务。英伟达 将向NEBIUS投资20亿美元，支持其在2030年底前实现超5吉瓦算力部署目标。(格隆汇) 英伟达(NVDA.US)涨1.4%，报187.4美元。消息面上，英伟达CEO黄仁勋罕见以个人名义发表长篇博 文"AI is a five layer cake"，他将AI产业架构形象地比作"五层蛋糕"：能源→芯片→基础设施→模型→应 用。黄仁勋写道："我们才刚刚开始这项建设。我们已经投入了数千亿美元。还有数万亿美元的基础设 施需要建设。" ...

Core Conclusion - China Taiping, a century-old comprehensive insurance group controlled by the Ministry of Finance, is leading the industry in the transformation of dividend insurance and optimizing its investment side, providing growth potential and value. The company is rated "Buy" for the first time due to its strategic determination backed by state-owned assets and its full-license collaborative advantages [1]. Group 1: Business Overview - The company is a state-owned comprehensive insurance group controlled by the Ministry of Finance, with a clear division of responsibilities within its management team. The life insurance segment is the cornerstone of its business, expected to account for 90.1% of segment profits by the first half of 2025, while property and casualty insurance and reinsurance businesses are operating steadily [1]. - By the first half of 2025, the total investment assets are projected to reach HKD 1.68 trillion, with fixed-income assets serving as the foundation and significant room for equity investments [1]. Group 2: Competitive Advantages - The company is leading in the transformation of dividend insurance, with a liability structure that continues to optimize. In the first half of 2025, the growth rate of dividend insurance is nearly 120%, with new individual and bancassurance long-term policies accounting for 97.5% and 85.8% respectively. The long-term stability of the dividend realization rate (average of 93% from 2014 to 2024) positions dividend insurance as a core tool for stabilizing net profit and net asset fluctuations, while providing a steady source of investable funds [1]. - The company adheres to a fixed-income strategy, with bond assets increasing to 76.5%, effectively mitigating market volatility. The equity position is currently low, indicating significant potential for increased investment. Historical performance shows that the company has demonstrated notable elasticity during market uptrends, and with enhanced equity research capabilities and resource allocation, investment returns are expected to see substantial growth [2]. - As a full-license insurance group, the company benefits from resource sharing and collaborative empowerment among its life, property, casualty, reinsurance, and asset management businesses. The state-controlled ownership structure provides long-term strategic stability, supporting business transformation and investment strategy optimization [2].

Group 1 - The U.S. Consumer Price Index (CPI) for February increased by 2.4% year-on-year, aligning with expectations, while geopolitical uncertainties continue to dominate risk pricing [1] - The stock market opened with mixed results: the Nasdaq rose by 0.33%, the S&P 500 increased by 0.16%, and the Dow Jones fell by 0.14% [1] - Oracle's stock surged nearly 12% following better-than-expected quarterly performance, with the CEO refuting the "SaaS apocalypse" narrative [1] - Nebius saw its stock rise over 10% after securing a $2 billion investment from Nvidia to support the deployment of over 5 gigawatts of computing power by the end of 2030 [1] - Uber's stock increased by 3.4% due to a partnership with Zoox to deploy autonomous taxis on its ride-hailing platform [1] - TSMC's stock rose by 1.7%, reporting a 22.2% year-on-year revenue increase in February, reaching NT$317.66 billion, marking a record high for the same period [1]

| 股份代號: | 01898 | | --- | --- | | 上市法國名稱: | 中國中煤能源股份有限公司 - H股 | | 日期 (日 / 月 / 年): | 11/02/2026 - 11/03/2026 | | 最后用品 | 大股東/董事/最高行政人員名 作出披露的 買入 / 曹出或涉及的 每股的平均價 | | 持有權益的股份數目 佔已發行的 有關事件的日 相關法 | | | --- | --- | --- | --- | --- | | | 枝分野目 | | 拉 * 长上 融资照 | 有投票權股期(日/月/ 份權益 | | | | | | 份自分市 年) | | production of the control of the control concerner of the career of the controlled in CS20260311E00030 | 1201(L) Funde Sino Life Insurance 7,826,000(L | HKD 14.1500 | 1.556.411.147(L) | 37.90(L)09/03/2026 | | | Co., Ltd. ...

| 表格序號 | 大股東/董事/最高行政人員名 作出披露的 買入 / 賣出或涉及的 每股的平均價 | | | | 持有權益的股份數目 佔已發行的有關事件的日 相關法 | | | --- | --- | --- | --- | --- | --- | --- | | | 股份數目 | 周末 | | | ( 請參閱上述 * 註 有投票權股期(日 / 月 / 份權益 | | | | | | | | 部 份百分比 年) | | | CS20260310E00326 | MGD Holdings | 1201(L) | 5.230.000(L | HKD 3.1020 | 196,440,000(L) | 10.94(L)10/03/2026 | 减持后，MGD Holdings最新持股数目为196,440,000股，持股比例由11.23%下降至10.94%。 | 股份代號: | 03983 | | --- | --- | | 上市法國名稱: | 中海石油化學股份有限公司 - H股 | | 日期 (日 / 月 / 年): | 11/02/2026 - 11/03/2026 | 格隆汇3月11日丨根据联交所最新权益披露资 ...

Core Viewpoint - The company has completed testing and adaptation work with NVIDIA AI Factory, resulting in a joint solution aimed at advancing AI intelligence upgrades for enterprises [1] Group 1: Company Developments - The company adheres to an open cooperation philosophy, collaborating with various ecosystem partners to promote AI intelligence upgrades in enterprises [1] - A joint solution has been formed with NVIDIA AI Factory to explore global markets in the field of AI intelligence upgrades [1] Group 2: Strategic Initiatives - The company and NVIDIA are jointly building an enterprise intelligent brain based on AI Factory, empowering global clients with intelligent upgrades for enterprise applications [1] - The company is actively seizing opportunities related to the upgrade of AI computing infrastructure [1]